ProPhase Labs Stock (NASDAQ: PRPH) stock price, news, charts, stock research, profile.
You can purchase shares of ProPhase Labs (NASDAQ:PRPH) through any online brokerage.
Other companies in ProPhase Labs’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Jaguar Health (NASDAQ:JAGX).
ProPhase Labs has a consensus price target of $11.00.
The stock price for ProPhase Labs (NASDAQ: PRPH) is $0.6276 last updated December 23, 2024 at 11:05 AM EST.
A quarterly cash dividend of 0.30 per share of Class A Common Stock. The quarterly cash dividend was payable on June 3, 2022 to stockholders of record on May 24, 2022.
ProPhase Labs’s Q4 earnings are confirmed for Friday, March 14, 2025.
There is no upcoming split for ProPhase Labs.
ProPhase Labs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.